Package 42291-369-50

{"route": ["ORAL"], "spl_id": "3ab21195-3410-4321-e063-6294a90a2204", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0342291368606"], "unii": ["U3H27498KS"], "rxcui": ["198427", "198428", "198429", "282401"], "spl_set_id": ["fcdb94a8-33be-6375-98ef-6933999d157f"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (42291-369-50)", "package_ndc": "42291-369-50", "marketing_start_date": "20150128"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (42291-369-60)", "package_ndc": "42291-369-60", "marketing_start_date": "20130410"}], "brand_name": "Lamotrigine", "product_id": "42291-369_3ab21195-3410-4321-e063-6294a90a2204", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "42291-369", "generic_name": "Lamotrigine", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "200 mg/1"}], "application_number": "ANDA079132", "marketing_category": "ANDA", "marketing_start_date": "20130410", "listing_expiration_date": "20261231"}